Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Piperidin-4-ol → HCID 57895147, 화합물
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Piperidin-4-ol | HCID 79341 | — |
| 반응물 | 1-(benzo[d][1,3]dioxol-5-yl)-N-(5-((dimethylamino)(2-methoxyphenyl)methyl)pyridin-2-yl)cyclopropanecarboxamide | HCID 44236497 | — |
| 반응물 | (6-(1-(Benzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)pyridin-3-yl)(2-methoxyphenyl)methyl methanesulfonate | HCID 57895126 | — |
| 생성물 | HCID 57895147 | HCID 57895147 | — |
반응 단계
1-(benzo[d][1,3]dioxol-5-yl)-N-(5-((4-hydroxypiperidin-1-yl)(2-methoxyphenyl)methyl)pyridin-2-yl)cyclopropanecarboxamide was prepared from (6-(1-(benzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)pyridin-3-yl)(2-methoxyphenyl)methyl methanesulfonate and 4-hydroxypiperidine in a manner analogous to that of 1-(benzo[d][1,3]dioxol-5-yl)-N-(5-((dimethylamino)(2-methoxyphenyl)methyl)pyridin-2-yl)cyclopropanecarboxamide.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08524910B2 |
| 출처 데이터셋 | uspto-grants-2013_09 |
| ORD ID | ord-d0c6d295624c4f6ea00504b7e6ad3e11 |
| 출처 메모 | uspto-grants-2013_09 |